不同癌症数据集的不对称整合,以识别与风险相关的变体和基因
Ruixuan Wang1, Lam Tran1, Benjamin Brennan1
1Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI 48109, United States.
Bioinformatics advances
|November 3, 2025
概括
整合多种癌症基因组学数据可以提高识别癌症风险基因的统计能力. 一种新的不对称方法有效地处理数据异质性,改善了与各种癌症风险相关的潜在遗传变异的发现.
科学领域:
- 基因组学就是基因组学.
- 癌症研究 癌症研究
- 生物统计学 生物统计学
背景情况:
- 癌症基因组研究旨在识别与风险相关的基因,但由于样本大小小,它的统计能力有限.
- 整合不同癌症的数据可以增加识别泛癌症风险基因的统计能力.
- 跨癌症的数据异质性对综合分析提出了重大挑战.
研究的目的:
- 适应和应用一种新的不对称整合方法来分析异质癌症基因型数据.
- 通过整合密歇根基因组学倡议的数据集来提高与癌症风险相关的基因的识别.
- 解决多种癌症基因组研究中数据异质性的挑战.
主要方法:
- 利用一种新的不对称整合方法来处理数据异质性并排除无助的数据集.
- 在密歇根基因组学倡议中应用该方法来整合来自匹配病例和对照个体的基因型数据.
- 采用条件后勤回归和顺序测试来管理匹配的病例控制设计和控制错误发现率 (FDR).
主要成果:
- 与单个分析相比,综合分析发现了更多与各种癌症风险相关的潜在遗传变异和基因.
- 非对称整合方法在管理不同癌症类型的数据异质性方面表现出有效性.
- 这种方法成功地提高了检测泛癌风险基因的统计能力.
结论:
- 适应的非对称整合方法是对异质癌症基因组数据集的综合分析的一个有希望的方法.
- 这种方法提高了识别与癌症风险相关的遗传变异和基因的能力.
- 开发的方法为未来的泛癌基因组研究提供了有价值的工具.
相关概念视频
Genome-wide Association Studies-GWAS
15.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.3K
Cancer-Critical Genes II: Tumor Suppressor Genes
9.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Cancer Survival Analysis
639
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
639
Cancers Originate from Somatic Mutations in a Single Cell
14.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.5K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K


